Belite Bio (BLTE) Assets Average (2023 - 2026)

Belite Bio's Assets Average history runs 4 years deep, the most recent figure standing at $795.9 million for Q1 2026.

• On a quarterly basis, Assets Average rose 403.21% year-over-year to $795.9 million in Q1 2026; TTM through Mar 2026 was $795.9 million, a 403.21% increase from a year earlier, with the FY2025 full-year figure at $466.3 million, up 277.95% from the prior year.
• Assets Average climbed to $795.9 million in Q1 2026 per BLTE's latest filing, from $531.5 million in the prior quarter.
• Across five years, Assets Average topped out at $795.9 million in Q1 2026 and bottomed at $42.0 million in Q1 2023.
• The 4-year median for Assets Average is $117.1 million (2024), against an average of $196.3 million.
• Across the five-year window, Assets Average surged 46.01% in 2025 and soared 403.21% in 2026, its largest moves.
• Year by year, Assets Average stood at $76.1 million in 2023, then jumped by 76.01% to $134.0 million in 2024, then soared by 296.69% to $531.5 million in 2025, then jumped by 49.76% to $795.9 million in 2026.
• Per Business Quant, the three latest BLTE Assets Average figures stand at $795.9 million (Q1 2026), $531.5 million (Q4 2025), and $219.4 million (Q3 2025).